Closure of Trading Window

Shukra Pharmaceuticals Ltd announced the closure of its trading window for designated persons, including promoters, directors, KMPs, and their immediate relatives. This measure, effective July 1, 2026, is in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window will remain closed until 48 hours after the company declares its unaudited financial results for the quarter ended June 30, 2026. This is a standard compliance procedure ahead of quarterly earnings announcements to prevent insider trading.